Cargando…
Choosing the right treatment for patients with a severe course of chronic non-bacterial osteomyelitis (CNO) - pamidronate or TNF-α blockade?
Autores principales: | Morbach, H, Schnabel, A, Bruck, N, Holl-Wieden, A, Girschick, H, Hedrich, C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4599862/ http://dx.doi.org/10.1186/1546-0096-13-S1-P190 |
Ejemplares similares
-
New Insights into Adult and Paediatric Chronic Non-bacterial Osteomyelitis CNO
por: Hedrich, Christian M., et al.
Publicado: (2020) -
Juvenile chronic non-bacterial osteomyelitis (CNO): Long term course of disease and response to treatment in a large institutional cohort
por: Schwarz, T, et al.
Publicado: (2015) -
P03-006 - Pamidronate rapidly decreases CRP and TNFΑ in CNO
por: Kostik, MM, et al.
Publicado: (2013) -
Chronic nonbacterial osteomyelitis (CNO) and chronic recurrent multifocal osteomyelitis (CRMO)
por: Zhao, Dan Yongdong, et al.
Publicado: (2021) -
Physical activity and health-related quality of life in chronic non-bacterial osteomyelitis
por: Julia, Nentwich, et al.
Publicado: (2019)